{"id":"doi:10.1200/jco.21.01497","kind":"review","title":"First-Line Immunotherapy for Non–Small-Cell Lung Cancer","authors":["Martin Reck","Jordi Remón","Matthew David Hellmann"],"author_count":3,"year":2022,"published":"2022-01-05","venue":"Journal of Clinical Oncology","cited_by":896,"doi":"10.1200/jco.21.01497","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1200/jco.21.01497","archive_url":"https://space-kitty.com/papers/doi:10.1200/jco.21.01497","updated":null,"pmid":"34985920","pmcid":null,"openalex_id":"W4205177974","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}